|
WO2019002407A1
|
|
Process for the preparation of tipiracil hydrochloride
|
|
WO2018193090A2
|
|
Process for preparation of eliglustat hemitartrate and intermediates thereof
|
|
WO2018172463A1
|
|
Process for the preparation of brexpiprazole
|
|
WO2018153925A1
|
|
Stable pharmaceutical compositions comprising macitentan
|
|
US2018177735A1
|
|
Stable Pharmaceutical Composition Of Phytonadione And A Novel Process For Preparation Thereof
|
|
WO2018041824A1
|
|
Stable pharmaceutical composition of ethacrynic acid
|
|
WO2018029264A1
|
|
Process for preparation of dapagliflozin and intermediates thereof
|
|
WO2017207719A1
|
|
Cyclophosphamide composition and method for preparation thereof
|
|
US2019194154A1
|
|
Polymorphic Forms Of Vortioxetine Hydrobromide Tert-Butanolate
|
|
US2019002471A1
|
|
Crystalline Form Of Ticagrelor
|
|
EP3374349A1
|
|
Process for the preparation of eltrombopag olamine
|
|
WO2017029377A1
|
|
Process for preparation of vortioxetine hydrobromide
|
|
US2017296666A1
|
|
Stable Pharmaceutical Composition Of Amorphous Ticagrelor
|
|
WO2016193482A1
|
|
Process for preparing clobazam using novel intermediates
|
|
EP3303343A1
|
|
Process for the preparation of darunavir
|
|
WO2016135065A1
|
|
Process for granulating sevelamer carbonate
|
